Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK, PD, and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07445906
What this trial is testing

RG002C0106 Injection in Adult Participants With Normal Renal Function and Mild-to-Moderate Renal Impairment

Who this might be right for
Renal ImpairmentsIgA Nephropathy (IgAN)
Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd. 24
Early research (Phase 1)Study completedNCT04483947
What this trial is testing

Assess Safety, Tolerability, PK and PD of AZD2693 in Non-alcoholic Steatohepatitis Patients

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
AstraZeneca 74
Early research (Phase 1)UnknownNCT03159832
What this trial is testing

Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Type 2 Diabetes Patients With Renal Insufficient

Who this might be right for
Renal Insufficiency,Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 24
Early research (Phase 1)Looking for participantsNCT07630545
What this trial is testing

A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.

Who this might be right for
Parkinson's Disease (PD)Mild to Moderate Parkinson's DiseaseEarly Stage Parkinson's Disease
Mission Therapeutics 106
Early research (Phase 1)Study completedNCT05413161
What this trial is testing

To Compare the PK, PD, Safety & Immunogenicity of ADL-018 in Healthy Subjects

Who this might be right for
Healthy
Kashiv BioSciences, LLC 306
Early research (Phase 1)Study completedNCT03624322
What this trial is testing

Safety and Tolerability of INP105 (Olanzapine by I231 POD® Device) Nasal Spray in Healthy Volunteers - SNAP 101

Who this might be right for
Acute Agitation
Impel Pharmaceuticals 38
Early research (Phase 1)Temporarily pausedNCT03722186
What this trial is testing

Safety, Tolerability and Pharmacokinetics/Pharmacodynamics (PK/PD) of SHR-1603 in Subjects With Advanced Malignancies

Who this might be right for
Physiological Effects of DrugsNeoplasms by Histologic TypeLymphoma+3 more
Jiangsu HengRui Medicine Co., Ltd. 128
Testing effectiveness (Phase 2)Temporarily pausedNCT04694586
What this trial is testing

Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and Pyrazinamide

Who this might be right for
Tuberculosis, Pulmonary
University Hospital, Linkoeping 40
Early research (Phase 1)Ended earlyNCT05515406
What this trial is testing

Investigate the Safety, Tolerability, PK, PD, and Efficacy of ONO-7018 in Patients With R/R NHL or CLL

Who this might be right for
Lymphoma, Non-HodgkinLeukemia, Lymphocytic, Chronic, B-Cell
Ono Pharmaceutical Co., Ltd. 9
Early research (Phase 1)Study completedNCT04157933
What this trial is testing

Staccato Apomorphine Multi-dose PK and PD in Patients With Parkinson's Disease

Who this might be right for
Parkinson's Disease
Alexza Pharmaceuticals, Inc. 35
Large-scale testing (Phase 3)Ended earlyNCT04472728
What this trial is testing

Efficacy and Safety of BIO101 in the Prevention of Respiratory Deterioration in Hospitalized COVID-19 Patients

Who this might be right for
Covid-19SARS-CoV2
Biophytis 238
Early research (Phase 1)Study completedNCT03218072
What this trial is testing

Evaluate Safety, Tolerability, PK and PD of HLX01 in Patients With CD20-positive B-cell Lymphomas

Who this might be right for
B-cell Lymphomas
Shanghai Henlius Biotech 12
Testing effectiveness (Phase 2)Study completedNCT04964557
What this trial is testing

Assess the Safety, Efficacy and Tolerability of AZD8233 Treatment in Participants With Hyperlipidaemia

Who this might be right for
Hyperlipidaemia
AstraZeneca 411
Early research (Phase 1)Study completedNCT06597799
What this trial is testing

First-in-human Study of MRT-6160 in Healthy Subjects

Who this might be right for
Healthy Volunteers
Monte Rosa Therapeutics, Inc 108
Early research (Phase 1)Study completedNCT01276119
What this trial is testing

The First Clinical Study to Test Safety, Blood Levels and Other Effects of CDP6038 in Healthy Males

Who this might be right for
Pharmacokinetics
UCB Pharma 67
Testing effectiveness (Phase 2)Study completedNCT04823611
What this trial is testing

AZD8233 in Participants With Dyslipidemia.

Who this might be right for
Dyslipidemia
AstraZeneca 87
Large-scale testing (Phase 3)Active Not RecruitingNCT05208281
What this trial is testing

A Multi-cohort Study of Safety, Efficacy, PK and PD of GNR-055 in Patients With Mucopolysaccharidosis Type II

Who this might be right for
Mucopolysaccharidosis Type IIMetabolic Diseases
AO GENERIUM 32
Early research (Phase 1)UnknownNCT05863442
What this trial is testing

Comparative PK, Safety, Tolerability, Immunogenicity, and PD Profile Study of TUR03 and Soliris in Healthy Participants

Who this might be right for
Healthy
Turgut Ardika PTY LTD 120
Early research (Phase 1)Active Not RecruitingNCT07350577
What this trial is testing

Evaluate the Safety, Tolerability, PK and PD of SAD of Intravenously Adminsterted ALTB-268 in Healthy Participants

Who this might be right for
Ulcerative Colitis (UC)
AltruBio Inc. 24
Early research (Phase 1)Study completedNCT06548945
What this trial is testing

A Phase I Study of GZR18 Injection in Obese/Overweight Subjects

Who this might be right for
Overweight and Obesity
Gan and Lee Pharmaceuticals, USA 16
Next Page